Valuation : Sartorius Stedim Biotech SA

Market Cap 18.13B 21.08B 17.1B 15.58B 29.13B 2,015B 29.39B 204B 78.39B 1,022B 79.15B 77.42B 3,247B P/E 2026 *
47.5x
P/E 2027 * 36.9x
Enterprise Value 20.13B 23.41B 19B 17.31B 32.35B 2,238B 32.65B 226B 87.08B 1,135B 87.92B 86B 3,606B EV / Sales 2026 *
6.44x
EV / Sales 2027 * 5.73x
Free-Float
28.47%
Yield 2026 *
0.45%
Yield 2027 * 0.54%
Manager TitleAgeSince
Chief Executive Officer 51 28/03/2023
Chief Tech/Sci/R&D Officer 61 08/09/2011
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 07/04/2015
Director/Board Member 69 07/04/2015
Director/Board Member 69 14/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.78%-4.99%-20.10%+2.61% 179B
-0.29%-1.59%-0.76%+14.58% 117B
-0.73%-4.82%+8.31%+80.61% 61.25B
-1.92%-6.01%+8.80%+41.11% 50.24B
-1.88%-5.97%-6.37%-33.87% 48.05B
+0.75%-5.80%+11.20%-19.01% 31.89B
-4.88%-11.48% - - 28.42B
+2.17%+0.44%+34.88%-12.44% 24.23B
+0.49%-7.65%-12.44%+4.86% 21.4B
Average -0.98%-5.18%+2.94%+9.81% 62.39B
Weighted average by Cap. -1.29%-4.24%-3.94%+12.66%

Financials

2026 *2027 *
Net sales 3.13B 3.64B 2.95B 2.69B 5.02B 348B 5.07B 35.14B 13.52B 176B 13.65B 13.35B 560B 3.47B 4.03B 3.27B 2.98B 5.57B 386B 5.62B 38.98B 15B 196B 15.15B 14.81B 621B
Net income 381M 443M 360M 328M 613M 42.4B 618M 4.29B 1.65B 21.51B 1.67B 1.63B 68.31B 483M 562M 456M 415M 776M 53.71B 783M 5.43B 2.09B 27.24B 2.11B 2.06B 86.53B
Net Debt 2.01B 2.34B 1.89B 1.73B 3.23B 223B 3.26B 22.57B 8.68B 113B 8.77B 8.58B 360B 1.76B 2.04B 1.66B 1.51B 2.82B 195B 2.85B 19.73B 7.59B 98.99B 7.67B 7.5B 314B
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!